Fabrice Viol

Hamburg, HH 20246, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Minimally Invasive Resection of Occult Insulinomas-Experience from an ENETS Centre of Excellence and Review of the Literature.

Minimally Invasive Resection of Occult Insulinomas-Experience from an ENETS Centre of Excellence and Review of the Literature.

Journal: Cancers

Published: October 21, 2025

Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma.

Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma.

Journal: Cancer letters

Published: January 27, 2025

Does gamma-glutamyltransferase correlate with liver tumor burden in neuroendocrine tumors?

Does gamma-glutamyltransferase correlate with liver tumor burden in neuroendocrine tumors?

Journal: Endocrine

Published: April 14, 2023

Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling.

Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling.

Journal: International journal of molecular sciences

Published: October 26, 2022

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy.

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: September 29, 2022

Cancer-Associated Fibroblasts Induce Proliferation and Therapeutic Resistance to Everolimus in Neuroendocrine Tumors through STAT3 Activation.

Cancer-Associated Fibroblasts Induce Proliferation and Therapeutic Resistance to Everolimus in Neuroendocrine Tumors through STAT3 Activation.

Journal: Neuroendocrinology

Published: February 25, 2022

High Serum Levels of Wnt Signaling Antagonist Dickkopf-Related Protein 1 Are Associated with Impaired Overall Survival and Recurrence in Esophageal Cancer Patients.

High Serum Levels of Wnt Signaling Antagonist Dickkopf-Related Protein 1 Are Associated with Impaired Overall Survival and Recurrence in Esophageal Cancer Patients.

Journal: Cancers

Published: August 07, 2021

Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors.

Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors.

Journal: Oncogenesis

Published: July 15, 2021

Targeting HDACs in Pancreatic Neuroendocrine Tumor Models.

Targeting HDACs in Pancreatic Neuroendocrine Tumor Models.

Journal: Cells

Published: May 10, 2021

Possible tumour cell reimplantation during curative endoscopic therapy of superficial Barrett's carcinoma.

Possible tumour cell reimplantation during curative endoscopic therapy of superficial Barrett's carcinoma.

Journal: Gut

Published: August 04, 2020

Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.

Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.

Journal: Endocrine pathology

Published: March 08, 2020

Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells.

Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells.

Journal: Cancer letters

Published: October 25, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026